Chinese companies have started halting the supply of pharmaceutical raw materials for drug production to Russia due to sanctions. The supply situation is expected to worsen as establishing domestic production of these raw materials in Russia is not a viable solution.

Chinese companies have started halting the supply of pharmaceutical raw materials for drug production to Russia due to sanctions. The supply situation is expected to worsen as establishing domestic production of these raw materials in Russia is not a viable solution.

Source: Alien_P3rsp3ktiv